These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33118012)

  • 1. New data on soluble ACE2 in patients with atrial fibrillation reveal potential value for treatment of patients with COVID-19 and cardiovascular disease.
    Sama IE; Voors AA; van Veldhuisen DJ
    Eur Heart J; 2020 Nov; 41(41):4047-4049. PubMed ID: 33118012
    [No Abstract]   [Full Text] [Related]  

  • 2. Could DIZE be the answer to COVID-19?
    Qaradakhi T; Gadanec L; Matsoukas J; Apostolopoulos V; Zulli A
    Maturitas; 2020 Oct; 140():83-84. PubMed ID: 32636103
    [No Abstract]   [Full Text] [Related]  

  • 3. Nasal ACE2 Levels and COVID-19 in Children.
    Patel AB; Verma A
    JAMA; 2020 Jun; 323(23):2386-2387. PubMed ID: 32432681
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms by which angiotensin-receptor blockers increase ACE2 levels.
    Ferrario CM; Ahmad S; Groban L
    Nat Rev Cardiol; 2020 Jun; 17(6):378. PubMed ID: 32332868
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 6. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research.
    Omar MB
    Heart Lung; 2020; 49(4):351. PubMed ID: 32327200
    [No Abstract]   [Full Text] [Related]  

  • 7. ACE2 is on the X chromosome: could this explain COVID-19 gender differences?
    Culebras E; Hernández F
    Eur Heart J; 2020 Jun; 41(32):3095. PubMed ID: 32577716
    [No Abstract]   [Full Text] [Related]  

  • 8. What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes?
    John TJ; John K
    Can J Cardiol; 2020 Jun; 36(6):969.e3. PubMed ID: 32299779
    [No Abstract]   [Full Text] [Related]  

  • 9. Blockade of SARS-CoV-2 infection by recombinant soluble ACE2.
    Alhenc-Gelas F; Drueke TB
    Kidney Int; 2020 Jun; 97(6):1091-1093. PubMed ID: 32354636
    [No Abstract]   [Full Text] [Related]  

  • 10. Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?
    Sanchis-Gomar F; Perez-Quilis C; Lavie CJ
    Eur Heart J; 2020 Jul; 41(32):3092-3093. PubMed ID: 32688380
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?
    Inciardi RM; Adamo M; Lupi L; Metra M
    Eur Heart J; 2020 Jul; 41(32):3094. PubMed ID: 32699894
    [No Abstract]   [Full Text] [Related]  

  • 12. Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19.
    Leow MKS
    Crit Care; 2020 Jul; 24(1):396. PubMed ID: 32631373
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link.
    Van den Eynde J; McCutcheon KRG
    Int J Cardiol; 2021 Jan; 322():293. PubMed ID: 32920066
    [No Abstract]   [Full Text] [Related]  

  • 15. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral cancer and ACE2 receptor of SARS-CoV-2.
    Martelli-Júnior H; Machado RA; Martelli DRB; Andrade MC; Coletta RD
    Oral Oncol; 2020 Sep; 108():104920. PubMed ID: 32713810
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19: is the ACE2 just a foe?
    Jakovac H
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1025-L1026. PubMed ID: 32233935
    [No Abstract]   [Full Text] [Related]  

  • 18. Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19.
    Abd El-Aziz TM; Al-Sabi A; Stockand JD
    Signal Transduct Target Ther; 2020 Nov; 5(1):258. PubMed ID: 33144565
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?
    Soldo J; Heni M; Königsrainer A; Häring HU; Birkenfeld AL; Peter A
    Diabetes Care; 2020 Oct; 43(10):e134-e136. PubMed ID: 32753456
    [No Abstract]   [Full Text] [Related]  

  • 20. Covid-19, ACE2 and the kidney.
    Hardenberg JB; Luft FC
    Acta Physiol (Oxf); 2020 Sep; 230(1):e13539. PubMed ID: 32662161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.